Curex Life Science Fund, LP is a hedge fund based in Nashville, Tennessee. According to its most recent Form D, filed Nov 24, 2025, the fund has sold $10,175,395 of interests to 34 investors since its first sale in Dec 2019. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Joshua Trantum; Keith Ferrari.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $10,175,395Cumulative sales reported on Form D
- Investors
- 34
- First sale
- Dec 3, 2019
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Joshua Trantum; Keith Ferrari
- Latest Form D
- Nov 24, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Curex Life Science Fund, LP
What is the minimum investment for Curex Life Science Fund, LP?
Curex Life Science Fund, LP's latest Form D, filed Nov 24, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Curex Life Science Fund, LP?
Curex Life Science Fund, LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Curex Life Science Fund, LP raised?
Curex Life Science Fund, LP reports $10,175,395 sold from 34 investors on its Form D filed Nov 24, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is Curex Life Science Fund, LP based?
Curex Life Science Fund, LP is based in Nashville, Tennessee.
When did Curex Life Science Fund, LP launch?
Curex Life Science Fund, LP reports its first sale in Dec 2019.
Size compared with every hedge fund
Raised more than 38% of the 56 hedge funds based in Tennessee, and more than 21% of all 10,307 that report sales.